0 Oxford Medical Intelligence Limited 08775711 false 2024-12-01 2025-11-30 2025-11-30 The principal activity of the company is the retail sale of medical and orthopaedic goods in specialised stores Digita Accounts Production Advanced 6.30.9574.0 true 08775711 2024-12-01 2025-11-30 08775711 2025-11-30 08775711 core:CurrentFinancialInstruments 2025-11-30 08775711 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 08775711 core:FurnitureFittingsToolsEquipment 2025-11-30 08775711 core:OtherPropertyPlantEquipment 2025-11-30 08775711 bus:SmallEntities 2024-12-01 2025-11-30 08775711 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 08775711 bus:FilletedAccounts 2024-12-01 2025-11-30 08775711 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 08775711 bus:RegisteredOffice 2024-12-01 2025-11-30 08775711 bus:Director1 2024-12-01 2025-11-30 08775711 bus:Director2 2024-12-01 2025-11-30 08775711 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 08775711 bus:Agent1 2024-12-01 2025-11-30 08775711 core:FurnitureFittings 2024-12-01 2025-11-30 08775711 core:FurnitureFittingsToolsEquipment 2024-12-01 2025-11-30 08775711 core:OtherPropertyPlantEquipment 2024-12-01 2025-11-30 08775711 core:PlantMachinery 2024-12-01 2025-11-30 08775711 countries:EnglandWales 2024-12-01 2025-11-30 08775711 2024-11-30 08775711 core:FurnitureFittingsToolsEquipment 2024-11-30 08775711 core:OtherPropertyPlantEquipment 2024-11-30 08775711 2023-12-01 2024-11-30 08775711 2024-11-30 08775711 core:CurrentFinancialInstruments 2024-11-30 08775711 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 08775711 core:FurnitureFittingsToolsEquipment 2024-11-30 08775711 core:OtherPropertyPlantEquipment 2024-11-30 xbrli:pure iso4217:GBP

Registration number: 08775711

Oxford Medical Intelligence Limited
Unaudited Filleted Financial Statements
for the Year Ended 30 November 2025

Oxford Medical Intelligence Limited

Contents

Company Information | 1
Accountants' Report | 2
Balance Sheet | 3
Notes to the Unaudited Financial Statements | 4 to 7

Oxford Medical Intelligence Limited

Company Information

Directors | Mr Yin-Chien Yeap Dr Philip Camilleri

Registered office | 4 South Bar Street Banbury Oxfordshire United Kingdom OX16 9AA

Accountants | ReesRussell Chartered Accountants4 South Bar Street Banbury Oxfordshire OX16 9AA

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Oxford Medical Intelligence Limited
for the Year Ended 30 November 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Oxford Medical Intelligence Limited for the year ended 30 November 2025 as set out on pages 3 to 7 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Oxford Medical Intelligence Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Oxford Medical Intelligence Limited and state those matters that we have agreed to state to the Board of Directors of Oxford Medical Intelligence Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Oxford Medical Intelligence Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Oxford Medical Intelligence Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Oxford Medical Intelligence Limited. You consider that Oxford Medical Intelligence Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Oxford Medical Intelligence Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................
ReesRussell
Chartered Accountants
4 South Bar Street
Banbury
Oxfordshire
OX16 9AA

3 August 2026

Oxford Medical Intelligence Limited

(Registration number: 08775711)
Balance Sheet as at 30 November 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 5 | 103 | 137
Current assets |  |  |
Debtors | 6 | 2,936 | 2,568
Cash at bank and in hand |  | 1,087 | 2,346
|  | 4,023 | 4,914
Creditors: Amounts falling due within one year | 7 | (7,354) | (7,042)
Net current liabilities |  | (3,331) | (2,128)
Net liabilities |  | (3,228) | (1,991)
Capital and reserves |  |  |
Called up share capital |  | 1,000 | 1,000
Retained earnings |  | (4,228) | (2,991)
Shareholders' deficit |  | (3,228) | (1,991)

For the financial year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 3 August 2026 and signed on its behalf by:

......................................... Dr Philip Camilleri Director

Oxford Medical Intelligence Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025

1 | General information

The address of its registered office is:
4 South Bar Street
Banbury
Oxfordshire
OX16 9AA
United Kingdom

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Oxford Medical Intelligence Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and machinery | 25% straight line
Fixtures and fittings | 25% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 2).

Oxford Medical Intelligence Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025

4 | Loss before tax

Arrived at after charging/(crediting)

| 2025 £ | 2024 £
Depreciation expense | 35 | 46

5 | Tangible assets

| Furniture, fittings and equipment £ | Plant and equipment £ | Total £
Cost or valuation
At 1 December 2024 | 2,642 | 18,540 | 21,182
At 30 November 2025 | 2,642 | 18,540 | 21,182
Depreciation
At 1 December 2024 | 2,505 | 18,540 | 21,045
Charge for the year | 34 | - | 34
At 30 November 2025 | 2,539 | 18,540 | 21,079
Carrying amount
At 30 November 2025 | 103 | - | 103
At 30 November 2024 | 137 | - | 137

6 | Debtors

Current | 2025 £ | 2024 £
Other debtors | 2,936 | 2,568
| 2,936 | 2,568

7 | Creditors

Creditors: amounts falling due within one year

Oxford Medical Intelligence Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025

| 2025 £ | 2024 £
Due within one year |  |
Accruals and deferred income | 1,780 | 1,780
Other creditors | 5,574 | 5,262
| 7,354 | 7,042